Conference LibraryGated
Capstan Therapeutics · in vivo CAR-T via LNP/mRNA (acquired by AbbVie)
Capstan Therapeutics · in vivo CAR-T 公司 · LNP/mRNA delivery 平台 · 2025 被 AbbVie 以 $2.1B 收购(per OPORD-002 verify priority list)。 AbbVie 此次收购是大药企第二轮进入 in vivo CAR-T 空间的明确信号。 对 SunVax 的对标维度:LNP 同 modality · therapeutic asset 不同 business model。
- Type
- company
- Domain
- conference
- Grade
- conference
- License
- LIGHT_HOPE_proprietary
- evidence_grade
- B
- category
- in_vivo_car_t_lnp_mrna
- status
- draft
- instance_tag
- sunvax-antibody-2025
- platform_tech
- LNP / mRNA · in vivo CAR-T delivery
- acquisitions
- [object Object]
Read-only aggregated view. Conference Library is the source of record; this catalog shows provenance as-is — no ratings, no reviews.